Springfield, Ohio (July 8, 2025)- Sheehan Brothers Vending is recalling its Cheeseburgers, Spicy Chicken Sandwich, Italian Mini Subs, Pepperoni Pizza Sub, Chili Cheese Coney and BBQ Riblet w/coleslaw due to…

Forensic Proteomics Applied to FDA-Regulated Products, July 31, 2025

CHS Inc. is voluntarily recalling seven tons of Payback® Champion Lamb Text B30 with Power Booster due to potentially elevated levels of copper. Symptoms of copper toxicity in sheep include lethargy and…

For active immunization of persons ages 6 months of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine.

KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that…

Active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. FLULAVAL is approved for use in persons 6 months of age and older.

For active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. FLUARIX is approved for use in persons aged 6 months and older.

Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment

For active immunization of persons 4 years of age and older for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

For the active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.